Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

HLA-B* 1502 screening: time to clinical practice.

Locharernkul C, Shotelersuk V, Hirankarn N.

Epilepsia. 2010 May;51(5):936-8. doi: 10.1111/j.1528-1167.2010.02549.x. No abstract available.

PMID:
20536533
[PubMed - indexed for MEDLINE]
2.

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.

Chang CC, Too CL, Murad S, Hussein SH.

Int J Dermatol. 2011 Feb;50(2):221-4. doi: 10.1111/j.1365-4632.2010.04745.x.

PMID:
21244392
[PubMed - indexed for MEDLINE]
3.

A marker for Stevens-Johnson syndrome ...: ethnicity matters.

Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC; RegiSCAR Group.

Pharmacogenomics J. 2006 Jul-Aug;6(4):265-8. Epub 2006 Jan 17.

PMID:
16415921
[PubMed - indexed for MEDLINE]
4.

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.

Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P.

Epilepsia. 2010 May;51(5):926-30. doi: 10.1111/j.1528-1167.2010.02533.x. Epub 2010 Mar 19.

PMID:
20345939
[PubMed - indexed for MEDLINE]
5.

HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions.

Kano Y, Hirahara K, Asano Y, Shiohara T.

Acta Derm Venereol. 2008;88(6):616-8. doi: 10.2340/00015555-0528. No abstract available.

PMID:
19002350
[PubMed - indexed for MEDLINE]
Free Article
6.

HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.

Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P.

Pain Pract. 2012 Mar;12(3):202-8. doi: 10.1111/j.1533-2500.2011.00479.x. Epub 2011 Jun 16.

PMID:
21676164
[PubMed - indexed for MEDLINE]
7.

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R; JSAR research group.

Epilepsia. 2010 Dec;51(12):2461-5. doi: 10.1111/j.1528-1167.2010.02766.x. Epub 2010 Nov 3.

PMID:
21204807
[PubMed - indexed for MEDLINE]
8.

HLA-B*1502 screening in carbamazepine and lamotrigine candidates of Asian background.

Hassan I.

Aust N Z J Psychiatry. 2012 Nov;46(11):1106-7. doi: 10.1177/0004867412455702. Epub 2012 Jul 25. No abstract available.

PMID:
22833576
[PubMed - indexed for MEDLINE]
9.

Letter: HLA B*1502 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India.

Shankarkumar U, Shah KN, Ghosh K.

Epilepsia. 2009 Jul;50(7):1837-8. doi: 10.1111/j.1528-1167.2009.02096.x. No abstract available.

PMID:
20831525
[PubMed - indexed for MEDLINE]
10.

Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.

Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK.

Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):579-82. doi: 10.4103/0378-6323.57718.

PMID:
19915237
[PubMed - indexed for MEDLINE]
Free Article
11.

HLA-B*1502 screening and toxic effects of carbamazepine.

Liao WP, Shi YW, Min FL.

N Engl J Med. 2011 Aug 18;365(7):672-3; author reply 673. doi: 10.1056/NEJMc1105467#SA2. No abstract available.

PMID:
21848471
[PubMed - indexed for MEDLINE]
12.

[Progress in genetic studies on severe cutaneous adverse reactions to anti-epileptic drugs].

He XL, Liu ZS.

Zhonghua Er Ke Za Zhi. 2012 Dec;50(12):906-8. Review. Chinese. No abstract available.

PMID:
23324146
[PubMed - indexed for MEDLINE]
13.

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY; Taiwan SJS Consortium.

N Engl J Med. 2011 Mar 24;364(12):1126-33. doi: 10.1056/NEJMoa1009717.

PMID:
21428768
[PubMed - indexed for MEDLINE]
Free Article
14.

Stratification of the risk of serious allergic cutaneous reactions with therapeutic management of trigeminal neuralgia.

Shakib K, Sinanan M.

Br J Oral Maxillofac Surg. 2011 Apr;49(3):235-6. doi: 10.1016/j.bjoms.2010.03.007. Epub 2010 Apr 28.

PMID:
20430493
[PubMed - indexed for MEDLINE]
15.

HLA-B*1502 screening and toxic effects of carbamazepine.

Phillips EJ, Mallal SA.

N Engl J Med. 2011 Aug 18;365(7):672; author reply 673. doi: 10.1056/NEJMc1105467#SA1. No abstract available.

PMID:
21848472
[PubMed - indexed for MEDLINE]
16.

Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.

Fernando SL, Broadfoot AJ.

CMAJ. 2010 Mar 23;182(5):476-80. doi: 10.1503/cmaj.090401. Epub 2009 Nov 23. No abstract available.

PMID:
19933789
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

For Asians only? The perils of ancestry-based drug prescribing.

Payne PW Jr.

J Law Med Ethics. 2008 Fall;36(3):585-8. doi: 10.1111/j.1748-720X.2008.307.x. No abstract available.

PMID:
18840252
[PubMed - indexed for MEDLINE]
18.

Pharmacogenetics of cutaneous adverse drug reactions.

Aihara M.

J Dermatol. 2011 Mar;38(3):246-54. doi: 10.1111/j.1346-8138.2010.01196.x. Review.

PMID:
21342226
[PubMed - indexed for MEDLINE]
19.

HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.

Ikeda H, Takahashi Y, Yamazaki E, Fujiwara T, Kaniwa N, Saito Y, Aihara M, Kashiwagi M, Muramatsu M.

Epilepsia. 2010 Feb;51(2):297-300. doi: 10.1111/j.1528-1167.2009.02269.x. Epub 2009 Aug 19.

PMID:
19694795
[PubMed - indexed for MEDLINE]
20.

Medical genetics: a marker for Stevens-Johnson syndrome.

Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT.

Nature. 2004 Apr 1;428(6982):486.

PMID:
15057820
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk